Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Syngenta AG    SYT

Delayed Quote. Delayed  - 04/29 10:05:48 pm
80.57 USD   +0.59%
04/28 SYNGENTA AG : ex-dividend day for special dividend
04/28 SYNGENTA AG : ex-dividend day for annual dividend
04/26 SYNGENTA : Annual General Meeting
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Syngenta AG : Syngenta share repurchases: end-year report

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/03/2013 | 07:05am CEST

BASEL, Switzerland, Jan. 3, 2013 /PRNewswire/ -- Syngenta has completed the share repurchases authorized by the Annual General Meeting on April 22, 2008. The authorization allowed for the repurchase of up to 10 percent of outstanding shares.

In total, 1,487,200 shares were repurchased between March 8, 2010 and end December 2012 through a second trading line on the SIX Swiss Exchange. This represents 1.5 percent of outstanding shares at the time of authorization and a total amount of $402 million.

In accordance with motions passed at the Annual General Meetings on April 19, 2011 and April 24, 2012 a total of 1,473,700 shares have been canceled. The company plans to propose the cancellation of the remaining 13,500 shares at a subsequent Annual General Meeting.

Syngenta is one of the world's leading companies with more than 26,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.

Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.

    Syngenta International AG Media contacts:              Analyst/Investor contacts:

    Media Office              Paul Barrett                 Jennifer Gough
    CH-4002 Basel             Switzerland  +41 61 323 2323 Switzerland  +41 61 323 5059
    Switzerland                                            USA              +1 202 737 6521
    Tel:  +41 61 323 2323
    Fax: +41 61 323 2424      Daniel Braxton               Lars Oestergaard
                              Switzerland  +41 61 323 2323 Switzerland  +41 61 323 6793
    www.syngenta.com                                       USA              +1 202 737 6520

SOURCE Syngenta

share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on SYNGENTA AG
04/28 SYNGENTA AG : ex-dividend day for special dividend
04/28 SYNGENTA AG : ex-dividend day for annual dividend
04/26 SYNGENTA : Annual General Meeting
04/20 SYNGENTA : First quarter 2016: resilient performance in challenging markets
04/20DJSyngenta Says ChemChina Deal on Track
04/20DJLexmark Agrees to Be Sold for $2.54 Billion -- WSJ
04/20DJSYNGENTA : First-Quarter Revenue Fell 7% on Strong Dollar
04/20DJLexmark to Be Sold for $2.54 Billion
04/20DJLexmark to Be Sold for About $2.54 Billion, or $40.50/Share -- 3rd Update
04/19DJLexmark to Be Sold for Enterprise Value of $3.6 Billion, or $40.50/Share -- 2..